April 25, 2026 Eli Lilly Acquires Kelonia Therapeutics for $3.2 Billion in Major Biotech Takeover Deal
April 18, 2026 Revolution Medicines’ Daraxonrasib Doubles Survival in Pancreatic Cancer Phase 3 Trial
